Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Australas J Dermatol ; 64(4): e340-e347, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37665122

ABSTRACT

INTRODUCTION: Most cutaneous squamous cell carcinomas (cSCC) have a good prognosis, there is a small group where metastasis and death occur and the evaluation of this risk is still cause for controversy. Tumour budding is a pattern of histological invasion that is an emerging risk factor in other solid tumours. OBJECTIVE: To examine the association between tumour budding and other known high-risk predictors in cSCC. In addition, the impact of tumour budding on overall survival (OS) and disease-specific survival (DSS) was analysed. METHOD: Retrospective study. It included patients with a diagnosis of non-genital cSCC by excisional biopsy at a university hospital, between 2010 and 2020. A pathologist re-analysed their histological slides and evaluated budding. Univariate and multivariate analyses were made to study the associations. RESULTS: 156 cSCC biopsies were found, and positive tumour budding was found in 13.5%. This correlated with worse DSS and OS. On univariate analysis, budding was correlated with the diameter, thickness of the tumour, histological grade, level of invasion, perineural and lymphovascular invasion, previous radiotherapy, recurrent tumours and lymph node metastasis (LNM). Multivariate analysis: tumour budding was associated with poorly differentiated tumours, prior radiotherapy and LNM. CONCLUSION: An association was found between tumour budding and most known risk factors in cSCC. We found findings that indicate that the presence of tumour budding is associated with a worse prognosis in terms of LNM, OS and DSS. This supports the results of previous work which has suggested that budding could be related to high-risk cSCC.


Subject(s)
Carcinoma, Squamous Cell , Skin Neoplasms , Humans , Carcinoma, Squamous Cell/pathology , Skin Neoplasms/pathology , Retrospective Studies , Neoplasm Recurrence, Local/pathology , Prognosis , Risk Factors , Lymphatic Metastasis , Neoplasm Staging
5.
Rev Chilena Infectol ; 39(3): 349-353, 2022 06.
Article in Spanish | MEDLINE | ID: mdl-36156698

ABSTRACT

Chromoblastomycosis is a fungal infection of the skin and subcutaneous tissue, of chronic evolution, caused by dematiaceous fungi. The disease occurs worldwide, mainly in tropical and subtropical regions, but in regions like Chile there is only one report of a human case more than 30 years ago. We present the case of a 46-year-old Haitian man, resident in Chile, with verrucous plaques in the right anterior tibial area of one year of evolution. The diagnosis of chromoblastomycosis was confirmed when muriform cells and dematiaceous colonies were observed in the histopathological analysis and the direct microscopy, respectively. After six months of treatment with systemic antimycotics and cryotherapy, complete remission of the lesions was achieved.


Subject(s)
Chromoblastomycosis , Antifungal Agents/therapeutic use , Chile , Chromoblastomycosis/diagnosis , Chromoblastomycosis/drug therapy , Chromoblastomycosis/microbiology , Haiti , Humans , Male , Microscopy , Middle Aged , Skin/microbiology
6.
Rev. chil. infectol ; 39(3): 349-353, jun. 2022. ilus
Article in Spanish | LILACS | ID: biblio-1407787

ABSTRACT

Resumen La cromoblastomicosis es una infección fúngica de la piel y del tejido subcutáneo, de evolución crónica, causada por hongos dematiáceos que se caracterizan por presentar melanina en su pared celular. La enfermedad se presenta en todo el mundo, principalmente en regiones tropicales y subtropicales. En Chile, solo hay un reporte de caso humano hace más de 30 años. Se presenta el caso de un varón de 46 años, haitiano, residente en Chile, con placas verrucosas en la zona tibial anterior de un año de evolución. El diagnóstico de cromoblastomicosis se confirmó al observar células muriformes en la histopatología y colonias dematiáceas en el cultivo micológico; además, en la miscroscopía directa se observaron conidias compatibles con Fonsecaea spp. Luego de seis meses de tratamiento con antimicóticos sistémicos y crioterapia, se logró la remisión completa de las lesiones.


Abstract Chromoblastomycosis is a fungal infection of the skin and subcutaneous tissue, of chronic evolution, caused by dematiaceous fungi. The disease occurs worldwide, mainly in tropical and subtropical regions, but in regions like Chile there is only one report of a human case more than 30 years ago. We present the case of a 46-year-old Haitian man, resident in Chile, with verrucous plaques in the right anterior tibial area of one year of evolution. The diagnosis of chromoblastomycosis was confirmed when muriform cells and dematiaceous colonies were observed in the histopathological analysis and the direct microscopy, respectively. After six months of treatment with systemic antimycotics and cryotherapy, complete remission of the lesions was achieved.


Subject(s)
Humans , Male , Middle Aged , Chromoblastomycosis/diagnosis , Chromoblastomycosis/drug therapy , Skin/microbiology , Chile , Chromoblastomycosis/microbiology , Haiti , Microscopy , Antifungal Agents/therapeutic use
7.
J Clin Epidemiol ; 127: 177-183, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32853762

ABSTRACT

OBJECTIVES: The Chilean health system mandates providers to ensure assistance under a guaranteed system, the Explicit Guarantees in Healthcare (EGH) program. The Health Ministry has developed clinical practice guidelines (CPGs), but independent assessment of their quality is lacking. STUDY DESIGN AND SETTING: We assessed all CPGs of the EGH program using Appraisal of Guidelines for Research & Evaluation II (AGREE II) tool for appraising quality, validity period, and last update. RESULTS: Eighty-six CPGs were published between 2005 and 2016. Only 15 (17.4%) were updated. The overall mean raw score was 4.18 (±0.98). The scaled scores for each domain were: Scope and objectives 79.7%, Stakeholder involvement 46.2%, Rigor of development 36.3%, Clarity of presentation 82.8%, Applicability 23.5%, and Editorial independence 39.2%. The highest items were: overall objectives described, population described, options for management clearly presented, and key recommendations easily identifiable. The worst evaluated items were: views and preferences of the target population, strengths and limitations of the body of evidence, methods for formulating the recommendations, external review by experts, and description of facilitators and barriers to application. CONCLUSION: Most Chilean CPGs included in the EGH program are outdated and show items that should be improved, mainly through a more rigorous methodology, the inclusion of patients in its development, and appropriate consideration of its applicability.


Subject(s)
Developing Countries , National Health Programs , Practice Guidelines as Topic/standards , Chile , Cross-Sectional Studies , Humans , Quality Improvement , Reproducibility of Results , Stakeholder Participation
8.
Int Wound J ; 16(6): 1503-1505, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31531944

ABSTRACT

Several treatments have been described for cutaneous loxoscelism (CL), but the quality of available evidence is insufficient for the elaboration of a therapeutic consensus. Dapsone has shown beneficial effects on stopping the inflammatory phenomenon and accelerating the recovery. It is recommended to start dapsone once the visceral involvement is ruled out if glucose-6-phosphate dehydrogenase levels are normal. Autologous fibroblast (AF) therapy is a novel therapy that has been successfully used in bioengineering as skin substitutes for surgical wounds and burns, diabetic and pressure ulcers, and other aesthetic purposes. Interestingly, there are no reports of AFs in CL. We present a case of CL in which the necrotic process was stabilised with dapsone, but the healing of the ulcer was not achieved. Three weekly applications of AFs 100 000/cm2 were performed on a biocompatible polymer matrix, with optimal response within 2 months. This represents the first report of AFs in CL, setting the stage for future studies.


Subject(s)
Fibroblasts/transplantation , Skin Ulcer/therapy , Skin/pathology , Animals , Female , Guided Tissue Regeneration/methods , Humans , Necrosis/therapy , Skin/injuries , Skin Ulcer/etiology , Spider Bites/complications , Tissue Scaffolds , Transplantation, Autologous , Young Adult
9.
Ophthalmic Epidemiol ; 25(5-6): 436-442, 2018.
Article in English | MEDLINE | ID: mdl-30081705

ABSTRACT

PURPOSE: Properly conducted controlled clinical trials (CCTs) provide the highest level of evidence for optimising decision-making in healthcare. Electronic search strategies do not exhaustively retrieve them, because of issues related to indexing, exclusion of journals in languages other than English, among others. A handsearch approach is therefore warranted. We aimed to identify all CCTs published in Ophthalmology journals in Spain, to describe their main features, and to submit them to the Cochrane Register of CCTs (CENTRAL). METHODS: After identifying all Spanish Ophthalmology Journals, we conducted a systematic handsearch following Cochrane guidelines. When appropriate, results were compared against electronic searches. A descriptive analysis was completed, including risk of bias assessment. RESULTS: We identified 18 eligible journals; 10 074 original articles, editorials, letters to the editor, abstracts and conference proceedings were assessed via handsearching for inclusion. Of these, 136 were subject to title and abstract screening, after which 102 were classified as CCTs. We identified three articles via electronic searches that had not been detected via handsearch, for a total of 105 CCTs. Among these, the most investigated pathologies were cataracts (32/105; 30.5%) and glaucoma (23/105 21.9%). Regarding risk of bias, 104/105 (99.0%) were deemed as "high risk of bias", mainly due to flaws in sequence generation and allocation concealment. 15/105 (14.3%) mentioned conflicts of interest, half of which had something to declare. No CCT reported adherence to CONSORT. CONCLUSION: Spanish Ophthalmology journals publish a low number of CCTs, with limited methodological quality. Handsearching was more sensitive than the electronic searching. Abbreviations CCT: Controlled clinical trial.


Subject(s)
Controlled Clinical Trials as Topic , Decision Making , Eye Diseases/therapy , Ophthalmology , Periodicals as Topic , Humans , Spain
11.
Bol. Hosp. Viña del Mar ; 74(2): 54-56, 2018.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1397502

ABSTRACT

El divertículo de Meckel (DM) es la regresión incompleta del conducto onfalomesentérico y representa la malformación congénita gastrointestinal más común, en alrededor de 2% de la población. Hasta un 4 a 6% se puede complicar, incluyendo sangrado gastrointestinal, obstrucción o inflamación diverticular. Al realizar una apendicectomía en blanco, debe explorarse como diagnóstico diferencial en el intraoperatorio. Se presenta el caso de un paciente operado por abdomen agudo de probable origen apendicular, sin embargo en el intraoperatorio se evidenció el apéndice cecal sano, pero cursando con una diverticulitis de Meckel. Se presenta además, una breve revisión de la literatura.


Meckel´s diverticulum is the most common congenital gastrointestinal malformation, present in 2% of the population, and is formed through incomplete regression of the omphalomesenteric duct. 4 to 6% show symptoms such as gastrointestinal bleeding, intestinal obstruction or diverticular inflammation. It should be considered in the differential diagnosis during surgery for suspected appendicitis. We present the case of a patient undergoing acute abdomen surgery for suspected appendicitis whose cecal appendix was healthy but who was found to have Meckel´s diverticulitis. We also present a brief review of the literature.

SELECTION OF CITATIONS
SEARCH DETAIL
...